PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-18

  1. 77 Posts.
    lightbulb Created with Sketch. 30
    That is so true. Nowhere can I find a forecast on spend. Not even the brokerage coverage goes there.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.